EFFECT OF COVID-19 DISEASE IN SMELL AND TASTE OF PATIENTS WITH MILD, MODERATE OR SEVERE SYMPTOMATOLOGY
1 other identifier
observational
100
1 country
1
Brief Summary
This is an observational data and recording study. The aim of our study is to investigate the effect of SARS-COV2 infection on patients' sense of smell and taste, through quality control measurements using optic analogue scale (VAS) in hospitalized and in home-quarantined patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 17, 2020
CompletedFirst Submitted
Initial submission to the registry
December 6, 2020
CompletedFirst Posted
Study publicly available on registry
December 8, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 31, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 30, 2021
CompletedSeptember 13, 2022
September 1, 2022
7 months
December 6, 2020
September 7, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
oflactory and taste dysfunction in SARS-CoV2 infection
4 WEEKS
Study Arms (2)
home-quarantined patients
home-quarantined patients
inhospitalized patients
inhospitalized patients
Interventions
A visual analog scale (VAS) is a measurement device used to quantify a subjective experience.
Eligibility Criteria
The study population will be divided in two groups. The first group will be consisted with positive patients that were referred to either the Emergency Department (ED) of Infectious Diseases or at the Outpatient Clinic screening for SARS-COV2 and are being self-quarantined at home. The participants of the second group will be hospitalized patients in the Infectious Diseases Unit (IDU) of the University General Hospital of Ioannina.
You may qualify if:
- adult\>18 years old
- COVID-19 positive patient, via RT-PCR test
- Patient referred to the University General Hospital of Ioannina
You may not qualify if:
- Age \<18
- Previous nasal surgery, endoscopic sinus surgery
- Head and neck radiotherapy
- Head injury
- Allergic rhinitis
- Chronis Rhinosinusitis
- Psychiatric/ Neurological disorders
- Disorders that altering the level of consciousness (Glasgow Coma Scale \<15)
- History of smell and taste disorder
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University General Hospital of Ioannina
Ioannina, Epirus, 45500, Greece
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
CHARALAMPOS MILIONIS, PROFESSOR
University Hospital, Ioannina
- PRINCIPAL INVESTIGATOR
IOANNIS KASTANIOUDAKIS, PROFESSOR
University Hospital, Ioannina
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- CONSULTANT OF INTERNAL MEDICINE
Study Record Dates
First Submitted
December 6, 2020
First Posted
December 8, 2020
Study Start
November 17, 2020
Primary Completion
May 31, 2021
Study Completion
June 30, 2021
Last Updated
September 13, 2022
Record last verified: 2022-09
Data Sharing
- IPD Sharing
- Will not share